Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis from a phase 2b, randomized, controlled trial

被引：0
|
作者：
Guttman-Yassky, Emma [1 ]
Beck, Lisa A. [2 ]
Anderson, Jaclyn K. [3 ]
Hu, Xiaofei [3 ]
Gu, Yihua [3 ]
Teixeira, Henrique D. [3 ]
Silverberg, Jonathan I. [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, Med Ctr, New York, NY 10029 USA
[2] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[3] AbbVie Inc, N Chicago, IL USA
[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
8318
引用
收藏
页码：AB294 / AB294
页数：1
相关论文
共 50 条
  • [31] Safety of amlitelimab in a Phase 2a clinical trial of patients with moderate-to-severe atopic dermatitis
    Weidinger, Stephan
    Cork, Michael
    Reich, Adam
    Bieber, Thomas
    Gilbert, Sally
    Quaratino, Sonia
    Wilson, Rosamund
    Porter-Brown, Ben
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [32] Safety of Amlitelimab in a Phase 2a Clinical Trial of Patients With Moderate-to-Severe Atopic Dermatitis
    Weidinger, Stephan
    Cork, Michael
    Reich, Adam
    Bieber, Thomas
    Gilbert, Sally
    Quaratino, Sonia
    Wilson, Rosamund
    Porter-Brown, Ben
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB221 - AB221
  • [33] UPADACITINIB VERSUS DUPILUMAB IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF THE HEADS UP PHASE 3 TRIAL
    Blauvelt, Andrew
    Teixeira, Henrique D.
    Simpson, Eric L.
    Costanzo, Antonio
    De Bruin-Weller, Marjolein
    Barbarot, Sebastien
    Prajapati, Vimal H.
    Lio, Peter
    Hu, Xiaofei
    Wu, Tianshuang
    Liu, John
    Ladizinski, Barry
    Chu, Alvina D.
    Eyerich, Kilian
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 62 - 62
  • [34] Upadacitinib for the treatment of moderate-to-severe atopic dermatitis in real-world clinical practice
    Tran, Vanessa
    Ross, Gayle
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 11 - 11
  • [35] Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
    Zeng, Linxi
    Feng, Sen
    Yao, Lulu
    Wang, Bin
    Zhang, Guoqiang
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 734 - 740
  • [36] Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics
    Thyssen, J. P.
    Thaci, D.
    Bieber, T.
    Gooderham, M.
    de Bruin-Weller, M.
    Soong, W.
    Kabashima, K.
    Barbarot, S.
    Luna, P. C.
    Xu, J.
    Hu, X.
    Liu, Y.
    Raymundo, E. M.
    Calimlim, B. M.
    Nduaka, C.
    Gamelli, A.
    Simpson, E. L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, : 1871 - 1880
  • [37] Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Gooderham, Melinda
    Chan, Gary
    Feeney, Claire
    Biswas, Pinaki
    Valdez, Hernan
    DiBonaventura, Marco
    Nduaka, Chudy
    Rojo, Ricardo
    JAMA DERMATOLOGY, 2020, 156 (08) : 863 - 873
  • [38] Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis in adolescents: A systematic review and meta-analysis of randomized controlled trials
    Huang, Lingmei
    Zhao, Danjie
    Lin, Haixia
    Zheng, Hong
    Li, Xia
    Chen, Long
    Tang, Peng
    MEDICINE, 2024, 103 (38)
  • [39] EFFICACY AND SAFETY OF CM310 IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2B TRIAL IN CHINA
    Zhang, Jianzhong
    Yang, Bin
    Li, Jingyi
    Ding, Yangfeng
    Wu, Liming
    Zhang, Litao
    Wang, Jinyan
    Zhu, Xiaohong
    Zhang, Furen
    Tao, Xiaohua
    Li, Yumei
    Zhang, Chunlei
    Li, Linfeng
    Lu, Jianyun
    Diao, Qingchun
    Lu, Qianjin
    Man, Xiaoyong
    Li, Fuqiu
    Xia, Xiujuan
    Cheng, Hao
    Zhao, Yan
    Chen, Bo
    Yan, Jinchun
    Zhao, Guoqing
    Jia, Yingmin
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 20 - 20
  • [40] DISCONTINUATION OF TOPICAL CORTICOSTEROIDS IN UPADACITINIB-TREATED PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS FROM THE AD UP PHASE 3 TRIAL
    Reich, Kristian
    Boguniewicz, Mark
    Kabashima, Kenji
    Barbarot, Sebastien
    Girolomoni, Giampiero
    Mendes-Bastos, Pedro
    Gamelli, Amy
    Liu, Yingyi
    Teixeira, Henrique
    Armstrong, April
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 61 - 61
12345